These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 10932875)

  • 1. [Not Available].
    Brotons Cuixart C; Alemán Sánchez JJ; Banegas Banegas JR; Fondón León C; Lobos-Bejarano JM; Martín Rioboó E; Navarro Pérez J; Orozco-Beltrán D; Villar Álvarez F;
    Aten Primaria; 2018 May; 50 Suppl 1(Suppl 1):4-28. PubMed ID: 29866357
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk factor thresholds: their existence under scrutiny.
    Law MR; Wald NJ
    BMJ; 2002 Jun; 324(7353):1570-6. PubMed ID: 12089098
    [No Abstract]   [Full Text] [Related]  

  • 3. Type 2 diabetes: treatment recommendations for reducing the risk of complications.
    Syed H
    Nurs Stand; 2023 Jul; 38(7):45-50. PubMed ID: 37183423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suboptimal use of cardioprotective drugs in newly treated elderly individuals with type 2 diabetes.
    Sirois C; Moisan J; Poirier P; Grégoire JP
    Diabetes Care; 2007 Jul; 30(7):1880-2. PubMed ID: 17384345
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduction of body iron stores and the prevention of type 2 diabetes.
    Mascitelli L; Pezzetta F
    Am J Med; 2007 Jan; 120(1):e13; author reply e15. PubMed ID: 17208061
    [No Abstract]   [Full Text] [Related]  

  • 6. [The FIELD study presented and published. Unconvincing results of fenofibrates in diabetic patients].
    Widimský J
    Vnitr Lek; 2006 Jan; 52(1):80-4. PubMed ID: 16526203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of ischemic cardiovascular complications in type 2 diabetes].
    Moulin P
    Journ Annu Diabetol Hotel Dieu; 2000; ():125-37. PubMed ID: 10932875
    [No Abstract]   [Full Text] [Related]  

  • 8. Primary prevention of cardiovascular events and type 2 diabetes: should we prioritize our interventions?
    Sultan A; Thuan JF; Avignon A
    Diabetes Metab; 2006 Dec; 32(6):559-67. PubMed ID: 17296509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lipid-lowering cardiovascular prevention in type 2-diabetes. Statins are effective according to the FIELD study].
    Båvenholm P; Attvall S; Nilsson PM
    Lakartidningen; 2006 Aug 30-Sep 5; 103(35):2462-6. PubMed ID: 17002161
    [No Abstract]   [Full Text] [Related]  

  • 10. The benefit of aspirin therapy in type 2 diabetes: what is the evidence?
    Sirois C; Poirier P; Moisan J; Grégoire JP
    Int J Cardiol; 2008 Sep; 129(2):172-9. PubMed ID: 18495263
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.